X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms at HLTH Conference

Content Team by Content Team
4th November 2019
in News
ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms at HLTH Conference

ConvergeHEALTH by Deloitte announced the launch of a robust platform for the health care ecosystem that supports two critically important patient journeys. MyPATH for Health and MyPATH for Connected Care work together to connect and support patients and their care teams across the patient experience — from clinical trials to treatment and beyond.

The MyPATH platform helps health systems, biopharmaceutical, medical device, and health plan innovators deliver next-generation patient support services and therapy management across the patient journey, improving their overall experience while cultivating a rich, real-world data set.

“Because of new interoperability standards and a growing ecosystem of connected devices, patients are increasingly in control of their health and wellness data,” said Brett Davis, principal, Deloitte Consulting LLP, and general manager, ConvergeHEALTH by Deloitte. “But to transform the patient experience — whether supporting virtual health or virtual clinical trials — the patient must be connected to a platform that supports new workflows and paradigms of delivering care and supporting clinical research. The ConvergeHEALTH MyPATH platform helps life sciences and health care organizations do just that for the patients they serve.”

MyPATH for Health

The challenges of living with a chronic or serious illness, including complex symptoms, side-effects and treatments, can make it difficult for patients to adhere to their care plans. This can lead to increased cost for care and missed opportunities to improve patients’ lives. MyPATH for Health is a digital solution that supports life science innovators for clinical trials and patient services by connecting patients, caregivers, providers and life sciences organizations. By connecting all stakeholders, MyPATH can transform patient engagement, create a connected care team, aim to improve outcomes, and cultivates a rich, real-world data set for analysis.

“There is a growing body of evidence showing the value of digital and patient engagement solutions,” said Christopher Zant, principal, Deloitte Consulting LLP, and chief digital officer, ConvergeHEALTH by Deloitte. “The shift to a patient-centric health care environment creates significant opportunity but also requires a new way of thinking and novel strategies to be successful. With MyPATH for Health, organizations are better equipped to support and empower patients to understand their health status and be their best selves.”

MyPATH for Health enables:

  • Care coordination
  • Medication and appointment reminders
  • Remote health and risk monitoring
  • 24/7 support network
  • Novel approaches for improving research and development
  • ePRO and consent management for clinical trials
  • Community and family support

MyPATH for Connected Care

With patients at the center of the evolving health care ecosystem, business needs to meet them where they are. Making the pivot to virtual care is essential to expanding access to care, improving clinical outcomes, increasing patient engagement and reducing costs. MyPATH for Connected Care is a digital health care platform that connects patients and care teams to deliver virtual care services through an effective, data-driven experience.

“The way a patient manages their condition on a day-to-day basis, whether at home, at work and on the go, has lasting impact on their health and the question becomes how can we leverage technology to help support their health longitudinally,” said Summer Knight, managing director, Deloitte Consulting LLP, and virtual health leader, ConvergeHEALTH. “MyPATH for Connected Care seeks to answer this question by delivering high-touch customer experiences across channels by enabling personalized treatment plans, more efficient workflows, and allows clinical teams and consumers to collaborate adjusting care plans based on real-time data generated from the patient.”

MyPATH for Connected Care enables:

  • A connected ecosystem to support patients and care teams at every stage and setting
  • Continuous strategies for building capabilities that deploy patient-centered virtual home care
  • A robust health data collection with a focus on care plan management
  • A holistic, personalized approach to care plans
  • The ability to empower patients, with user friendly devices and wearables

About Deloitte

Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 5,000 private and middle market companies. Our people work across the industry sectors that drive and shape today’s marketplace — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Our network of member firms in more than 150 countries and territories serves four out of five Fortune Global 500® companies. Learn how Deloitte’s approximately 286,000 people make an impact that matters at www.deloitte.com.

 

Previous Post

Syneos Health Signs New Service Agreement With Pfizer

Next Post

SP Industries Acquires Spanish Sterile Filling Line Company i-Dositecno

Related Posts

Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Next Post
SP Industries Acquires Spanish Sterile Filling Line Company i-Dositecno

SP Industries Acquires Spanish Sterile Filling Line Company i-Dositecno

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In